El International Patient Decision Aid Standards (IPDAS, 2013) establecio criterios para mejorar los contenidos, desarrollos, implementacion y evaluacion de documentacion ofrecida a los pacientes, familiares, profesionales, investigadores y responsables politicos, frente a determinadas tomas de decisiones en el area de salud.
Manual con criterios de evaluacion y validacion de las herramientas de ayuda para la toma de decisiones (Basado en los criterios de The International Patin Decision Aid Standards (IPDAS) collaboration quality dimensions: Checklist & manual) [Manual evaluation criteria and validation help tools for decision making (Based in The International Patin Decision Aid Standards (IPDAS) collaboration quality dimensions: Checklist & manual)].
The winners of the International Package Design Awards (IPDA
) competition were announced and trophies were presented at the Jacob K.
The International Patient Decision Aids Standard (IPDAS
) Collaboration: The checklist, the instrument, and the next step.
For screening tests, the IPDAS guidelines assert, the decision aid should disclose the probability of a patient receiving a "true positive, true negative, false positive and false negative test result," as well as the "chance of disease being found with and without screening." (33)
(42) Noting this differential effect, IPDAS recommends that decision aids should present quantitative information both positively and negatively, to avoid biasing individuals one way or the other.
In a recent review article McDonald, Charles & Gafni (57) explored the available evidence and theoretical (conceptual) support used by members of the IPDAS Collaboration to justify the inclusion of the specific quality criteria found in the domain on presenting to patients probability information on treatment benefits and risks.
But the promotion and implementation of the internationally developed IPDAS standards for assessing DA and for possible certification also seems premature.
These decision aids generally rated fairly high on the IPDAS criteria, which are also available on the OHRI web site.
Again, these decision aids generally perform well against the IPDAS criteria.
In the current study, we calculated kappas as a measure of IPDA for H&E-only and H&E/mucin/lHC stain diagnoses of 54 NSCLC cases by 22 pathologists (231 possible pathologist pairs), using 4 current and recent NSCLC diagnostic classifications.
IPDA significantly improved when pathologists were provided with mucin and IHC stains in addition to H&E stains, compared to IPDA when using H&E alone (Table 7).